27 related articles for article (PubMed ID: 16908378)
1. Identifying risk factors using a skin cancer screening program.
Etzkorn JR; Parikh RP; Marzban SS; Law K; Davis AH; Rawal B; Schell MJ; Sondak VK; Messina JL; Rendina LE; Zager JS; Lien MH
Cancer Control; 2013 Oct; 20(4):248-54. PubMed ID: 24077401
[TBL] [Abstract][Full Text] [Related]
2. [The 'freckle bus'; an unhealthy phenomenon or a sober-minded experiment?].
Rampen FH
Ned Tijdschr Geneeskd; 1991 Feb; 135(7):295. PubMed ID: 2020333
[No Abstract] [Full Text] [Related]
3. The importance of test positive predictive value in ovarian cancer screening.
Greene MH; Feng Z; Gail MH
Clin Cancer Res; 2008 Nov; 14(22):7574; author reply 7577-9. PubMed ID: 18948386
[No Abstract] [Full Text] [Related]
4. Screening for skin cancer: recommendations and rationale.
Am Fam Physician; 2002 Apr; 65(8):1623-6. PubMed ID: 11989639
[No Abstract] [Full Text] [Related]
5. The value of different screening tests in predicting prostate biopsy outcome in screening for prostate cancer data from a multicenter study (ERSPC).
Roobol MJ; Zappa M; Määttänen L; Ciatto S
Prostate; 2007 Mar; 67(4):439-46. PubMed ID: 17192912
[TBL] [Abstract][Full Text] [Related]
6. [Skin cancer screening at the family doctor's office].
Gauwerky K; Ruzicka T; Berking C
MMW Fortschr Med; 2009 Jun; 151(25):38-42; quiz 43. PubMed ID: 19739523
[No Abstract] [Full Text] [Related]
7. Positive predictive value of skin cancer screening.
Marks R
J Am Acad Dermatol; 2006 Sep; 55(3):544-5; author reply 545-6. PubMed ID: 16908378
[No Abstract] [Full Text] [Related]
8. Increased cancer risk for individuals with a family history of prostate cancer, colorectal cancer, and melanoma and their associated screening recommendations and practices.
Noe M; Schroy P; Demierre MF; Babayan R; Geller AC
Cancer Causes Control; 2008 Feb; 19(1):1-12. PubMed ID: 17906935
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of phenotypic variables for skin cancer: risk assessment beyond skin typing.
Xu LY; Koo J
Int J Dermatol; 2006 Nov; 45(11):1275-83. PubMed ID: 17076706
[No Abstract] [Full Text] [Related]
10. [Identification of new ovarian cancer biomarkers with proteomic analyses--the diagnostic tool of the future?].
Petri AL; Høgdall E; Engelholm SA; Christensen IJ; Kjaer SK; Høgdall CK
Ugeskr Laeger; 2007 Aug; 169(33):2614-9. PubMed ID: 17725906
[TBL] [Abstract][Full Text] [Related]
11. Cancer screening in end-stage renal disease.
Rao SN
Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):737-40. PubMed ID: 19736467
[TBL] [Abstract][Full Text] [Related]
12. [Colorectal cancer screening should be evaluated in Swedish studies].
Blom J
Lakartidningen; 2008 Sep 17-23; 105(38):2564-7. PubMed ID: 18846858
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
